The race to develop a drug to treat Alzheimer's disease is afoot. If any drug currently in development can pull off the unprecedented feat of improving cognition in Alzheimer's patients, it could be "the most commercially successful drug in history," one expert said. Here's how a publicly traded Austin company fits into the mix.
